{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:23:27Z","timestamp":1794313407381,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.waojou.2022.100647","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T14:11:52Z","timestamp":1652969512000},"page":"100647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Severe asthma treatment patterns: A multicenter observational study in the Gulf region"],"prefix":"10.1016","volume":"15","author":[{"given":"Mona","family":"Al-Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mobayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Al Busaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Nizam","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Al Mubaihsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Khadadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuzakouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateen","family":"Uzbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Al Zaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anai.2013.06.016","article-title":"A\u00a0new phenotype of asthma: chest tightness as the sole presenting manifestation","volume":"111","author":"Shen","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2022.100647_bib2","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1172\/JCI84144","article-title":"Current concepts of severe asthma","volume":"126","author":"Ray","year":"2016","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.waojou.2022.100647_bib3","series-title":"Global Strategy for Asthma Management and Prevention","year":"2018"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12890-018-0621-9","article-title":"Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program","volume":"18","author":"Tarraf","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"9","key":"10.1016\/j.waojou.2022.100647_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","author":"Soriano","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2466-12-4","article-title":"Population prevalence of asthma and its determinants based on European Community Respiratory Health Survey in the United Arab Emirates","volume":"12","author":"Mahboub","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"8","key":"10.1016\/j.waojou.2022.100647_bib7","first-page":"1015","article-title":"Asthma insights and reality in the Gulf and the near East","volume":"13","author":"Khadadah","year":"2009","journal-title":"Int J Tubercul Lung Dis"},{"issue":"931","key":"10.1016\/j.waojou.2022.100647_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/pmj.79.931.259","article-title":"Management of asthma in adults: current therapy and future directions","volume":"79","author":"Green","year":"2003","journal-title":"Postgrad Med"},{"issue":"Suppl 1","key":"10.1016\/j.waojou.2022.100647_bib9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0954-6111(12)00462-3","article-title":"A\u00a0new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice?","volume":"106","author":"Papi","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.waojou.2022.100647_bib10","series-title":"Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma","year":"2007"},{"issue":"11","key":"10.1016\/j.waojou.2022.100647_bib11","article-title":"Addition of long-acting \u03b22 agonists to inhaled corticosteroids for chronic asthma in children","author":"Chauhan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.waojou.2022.100647_bib12","series-title":"Global Strategy for Asthma Management and Prevention","year":"2020"},{"issue":"S2","key":"10.1016\/j.waojou.2022.100647_bib13","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.5694\/mja18.00207","article-title":"Health-related quality of life burden in severe asthma","volume":"209","author":"McDonald","year":"2018","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/resp.12957","article-title":"Severe asthma: current management, targeted therapies and future directions-A roundtable report","volume":"22","author":"McDonald","year":"2017","journal-title":"Respirology (Carlton, Vic)."},{"issue":"4","key":"10.1016\/j.waojou.2022.100647_bib15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00125-2017","article-title":"An algorithmic approach for the treatment of severe uncontrolled asthma","volume":"4","author":"Zervas","year":"2018","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00004-2017","article-title":"Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy","volume":"3","author":"Brusselle","year":"2017","journal-title":"ERJ Open Res"},{"issue":"11","key":"10.1016\/j.waojou.2022.100647_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anai.2017.05.016","article-title":"Point-of-care blood eosinophil count in a severe asthma clinic setting","volume":"119","author":"Heffler","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib21","doi-asserted-by":"crossref","first-page":"1891725","DOI":"10.1080\/20018525.2021.1891725","article-title":"Fractional exhaled nitric oxide as a determinant for the clinical course of asthma: a systematic review","volume":"8","author":"Ulrik","year":"2021","journal-title":"Eur Clin Respir J"},{"issue":"8","key":"10.1016\/j.waojou.2022.100647_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/02770900802126958","article-title":"The predictive value of IgE as biomarker in asthma","volume":"45","author":"Ahmad Al Obaidi","year":"2008","journal-title":"J Asthma"},{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.alit.2017.02.003","article-title":"Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma","volume":"66","author":"Nagasaki","year":"2017","journal-title":"Allergol Int"},{"issue":"13","key":"10.1016\/j.waojou.2022.100647_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.waojou.2022.100647_bib25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.waojou.2022.100647_bib26","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.waojou.2022.100647_bib27","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.waojou.2022.100647_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the asthma quality of life questionnaire","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.waojou.2022.100647_bib29","series-title":"Pocket Guide for Asthma Management and Prevention (For Adults and Children Older than 5 Years)","year":"2019"},{"key":"10.1016\/j.waojou.2022.100647_bib30","series-title":"Difficult-to-treat and Severe Asthma in Adoloscent and Adult Patients: Diagnosis and Management","year":"2018"},{"issue":"10","key":"10.1016\/j.waojou.2022.100647_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/17476348.2017.1236688","article-title":"Improving the diagnosis of eosinophilic asthma","volume":"10","author":"Coumou","year":"2016","journal-title":"Expet Rev Respir Med"},{"issue":"2","key":"10.1016\/j.waojou.2022.100647_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1524-4733.2007.00229.x","article-title":"Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma","volume":"11","author":"Chen","year":"2008","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40413-017-0159-y","article-title":"Severe asthma and quality of life","volume":"10","author":"Hossny","year":"2017","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-018-0047-4","article-title":"Biomarkers in asthma: state of the art","volume":"4","author":"Tiotiu","year":"2018","journal-title":"Asthma Res Pract"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1465-9921-14-48","article-title":"Role of exhaled nitric oxide as a predictor of atopy","volume":"14","author":"Romero","year":"2013","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.waojou.2022.100647_bib37","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.rmed.2007.06.031","article-title":"Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma","volume":"101","author":"Boulet","year":"2007","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/oby.2007.7","article-title":"BMI and health status among adults\u00a0with asthma","volume":"16","author":"Vortmann","year":"2008","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/resp.13014","article-title":"Can biomarkers help us hit targets in difficult-to-treat asthma?","volume":"22","author":"Fricker","year":"2017","journal-title":"Respirology (Carlton, Vic)"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib40","first-page":"1003","article-title":"Biomarkers for diagnosis and management of eosinophilic asthma","volume":"1","author":"Syabbalo","year":"2020","journal-title":"Ann Clin Med Res"},{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.chest.2016.07.009","article-title":"Measuring eosinophils to make treatment decisions in asthma","volume":"150","author":"Nair","year":"2016","journal-title":"Chest"},{"issue":"suppl 60","key":"10.1016\/j.waojou.2022.100647_bib42","first-page":"PA1110","article-title":"Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma","volume":"48","author":"Austin","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12931-019-1056-4","article-title":"Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis","volume":"20","author":"Prazma","year":"2019","journal-title":"Respir Res"},{"issue":"10","key":"10.1016\/j.waojou.2022.100647_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/psb.1872","article-title":"Summary of ERS\/ATS guideline on managing severe asthma","volume":"31","author":"Chaplin","year":"2020","journal-title":"Prescriber"},{"key":"10.1016\/j.waojou.2022.100647_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/BTT.S157183","article-title":"New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic","volume":"13","author":"Caminati","year":"2019","journal-title":"Biol Targets Ther"},{"issue":"5","key":"10.1016\/j.waojou.2022.100647_bib46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.waojou.2022.100647_bib47","first-page":"Fc01","article-title":"Clinical utility of fractional exhaled nitric oxide (FeNO) as a biomarker to predict severity of disease and response to inhaled corticosteroid (ICS) in asthma patients","volume":"10","author":"Neelamegan","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.waojou.2022.100647_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2045-7022-3-37","article-title":"Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care","volume":"3","author":"Price","year":"2013","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2022.100647_bib49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2016.19627","article-title":"Reevaluation of diagnosis in adults with physician-diagnosed asthma","volume":"317","author":"Aaron","year":"2017","journal-title":"JAMA"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455122000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455122000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:44:53Z","timestamp":1761849893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455122000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1939455122000230"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2022.100647","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe asthma treatment patterns: A multicenter observational study in the Gulf region","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2022.100647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100647"}}